SCHEMBL9059358

SCHEMBL9059358

CCN(CC)C(N)=Nc1ccccc1N1CCOCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 5/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KCNQ2 O43526 1/20 0.39
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LMNA P02545 3/20 0.38
NPSR1 Q6W5P4 1/20 0.38
AKR1C3 P42330 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
RECQL P46063 1/20 0.37
POLB P06746 2/20 0.36
NSD2 O96028 1/20 0.36
MAPT P10636 1/20 0.36
PKM P14618 2/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9059357 1.00 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL9424226 0.90 SMN1; SMN2 (0.39) SMN1; SMN2ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL9424227 0.90 SMN1; SMN2 (0.39) SMN1; SMN2ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL9424083 0.88 PIK3CD (0.36) SMN1; SMN2ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL9424085 0.88 PIK3CD (0.36) SMN1; SMN2ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL9424203 0.86 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL9424206 0.86 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL6553147 0.86 SIGMAR1 (0.40) SMN1; SMN2ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL2707104 0.86 SIGMAR1 (0.40) SMN1; SMN2ALDH1A1L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL9424101 0.85 SIGMAR1 (0.39) SMN1; SMN2ALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 EP claimed
CN-1037346-C Therapeutic agents BOOTS CO LTD (GB) 1998-02-11 CN disclosed
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
US-5373008-A Phenylamidine and phenylguanidine derivatives and their use as anti-diabetic agents THE BOOTS COMPANT PLC. (GB) 1994-12-13 US disclosed
US-5223498-A Hypoglycemic agents THE BOOTS COMPANY PLC (GB) 1993-06-29 US disclosed
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 EP disclosed
CN-1057648-A Therapeutical agent BOOTS CO PLC (GB) 1992-01-08 CN disclosed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 EP disclosed